These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1004 related articles for article (PubMed ID: 21813460)

  • 21. Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus.
    Tamulaitis G; Kazlauskiene M; Manakova E; Venclovas Č; Nwokeoji AO; Dickman MJ; Horvath P; Siksnys V
    Mol Cell; 2014 Nov; 56(4):506-17. PubMed ID: 25458845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The population and evolutionary dynamics of phage and bacteria with CRISPR-mediated immunity.
    Levin BR; Moineau S; Bushman M; Barrangou R
    PLoS Genet; 2013; 9(3):e1003312. PubMed ID: 23516369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas systems and RNA-guided interference.
    Barrangou R
    Wiley Interdiscip Rev RNA; 2013; 4(3):267-78. PubMed ID: 23520078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A truncated anti-CRISPR protein prevents spacer acquisition but not interference.
    Philippe C; Morency C; Plante PL; Zufferey E; Achigar R; Tremblay DM; Rousseau GM; Goulet A; Moineau S
    Nat Commun; 2022 May; 13(1):2802. PubMed ID: 35589712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput analysis of type I-E CRISPR/Cas spacer acquisition in E. coli.
    Savitskaya E; Semenova E; Dedkov V; Metlitskaya A; Severinov K
    RNA Biol; 2013 May; 10(5):716-25. PubMed ID: 23619643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DnaQ exonuclease-like domain of Cas2 promotes spacer integration in a type I-E CRISPR-Cas system.
    Drabavicius G; Sinkunas T; Silanskas A; Gasiunas G; Venclovas Č; Siksnys V
    EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29891635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes and characterization of chromosomal self-targeting by native CRISPR-Cas systems in Streptococcus thermophilus.
    Cañez C; Selle K; Goh YJ; Barrangou R
    FEMS Microbiol Lett; 2019 May; 366(9):. PubMed ID: 31077282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short motif sequences determine the targets of the prokaryotic CRISPR defence system.
    Mojica FJM; Díez-Villaseñor C; García-Martínez J; Almendros C
    Microbiology (Reading); 2009 Mar; 155(Pt 3):733-740. PubMed ID: 19246744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatiotemporal Control of Type III-A CRISPR-Cas Immunity: Coupling DNA Degradation with the Target RNA Recognition.
    Kazlauskiene M; Tamulaitis G; Kostiuk G; Venclovas Č; Siksnys V
    Mol Cell; 2016 Apr; 62(2):295-306. PubMed ID: 27105119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of the CRISPR-Cas systems in Streptococcus thermophilus strains isolated from traditional yogurts.
    Özcan A; Yıbar A; Kiraz D; Ilıkkan ÖK
    Antonie Van Leeuwenhoek; 2024 Apr; 117(1):63. PubMed ID: 38561518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cas3 is a single-stranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system.
    Sinkunas T; Gasiunas G; Fremaux C; Barrangou R; Horvath P; Siksnys V
    EMBO J; 2011 Apr; 30(7):1335-42. PubMed ID: 21343909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRISPR analysis of bacteriophage-insensitive mutants (BIMs) of industrial Streptococcus thermophilus--implications for starter design.
    Mills S; Griffin C; Coffey A; Meijer WC; Hafkamp B; Ross RP
    J Appl Microbiol; 2010 Mar; 108(3):945-955. PubMed ID: 19709335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
    Majsec K; Bolt EL; Ivančić-Baće I
    BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid Multiplex Creation of Escherichia coli Strains Capable of Interfering with Phage Infection Through CRISPR.
    Strotksaya A; Semenova E; Savitskaya E; Severinov K
    Methods Mol Biol; 2015; 1311():147-59. PubMed ID: 25981471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages.
    Hynes AP; Villion M; Moineau S
    Nat Commun; 2014 Jul; 5():4399. PubMed ID: 25056268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR-Cas adaptation in Escherichia coli.
    Mitić D; Bolt EL; Ivančić-Baće I
    Biosci Rep; 2023 Mar; 43(3):. PubMed ID: 36809461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The endless battle between phages and CRISPR-Cas systems in
    Philippe C; Moineau S
    Biochem Cell Biol; 2021 Aug; 99(4):397-402. PubMed ID: 33534660
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral diversity threshold for adaptive immunity in prokaryotes.
    Weinberger AD; Wolf YI; Lobkovsky AE; Gilmore MS; Koonin EV
    mBio; 2012 Dec; 3(6):e00456-12. PubMed ID: 23221803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physical model of the immune response of bacteria against bacteriophage through the adaptive CRISPR-Cas immune system.
    Han P; Niestemski LR; Barrick JE; Deem MW
    Phys Biol; 2013 Apr; 10(2):025004. PubMed ID: 23492852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strong bias in the bacterial CRISPR elements that confer immunity to phage.
    Paez-Espino D; Morovic W; Sun CL; Thomas BC; Ueda K; Stahl B; Barrangou R; Banfield JF
    Nat Commun; 2013; 4():1430. PubMed ID: 23385575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.